Virulent strains of Mycoplasma pneumoniae, PI-1428 and M129, were radiolabeled with [3H]palmitic acid or [3H]thymidine and examined for attachment to hamster tracheal organ cultures, tracheal outgrowth monolayers, human 0-positive erythrocytes, and human WiDr carcinoma cell cultures. Although attachment to each cell substrate was readily detected, the WiDr cell culture monolayers provided the most satisfactory substrate for quantitating mycoplasma attachment. Serious technical limitations were encountered with each of the other substrates that we examined; these limitations interfered with reproducibility or sensitivity and rendered tracheal organ cultures and erythrocyte suspensions unsuitable for routine attachment and attachment inhibition assays. Moreover, the WiDr cell monolayer was the most sensitive substrate for determuning attachment inhibition activity in protein-containing extracts prepared from M. pneumoniae. The significance of these findings is discussed.
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Infection with Mycoplasma pneumoniae causes upper respiratory disease and primary atypical pneumonia (7) , especially in children and young adults (15) . During infection, M. pneumoniae attaches to and colonizes the mucous membranes of the respiratory tract but rarely invades parenchymal tissues (8, 10, 12) . Attachment is an important step in the initiation of infection (9, 22) and may help to protect the mycoplasma from the defense mechanisms of the host. Hence, inhibiting attachment may inhibit infection and provide an effective means of preventing disease. A protein extract of M. pneumoniae has been prepared that has binding activity (6) . The mycoplasma binding component provides an important immunogen which may elicit host response to prevent attachment and protect against M. pneumoniae disease. The protein extract can protect hamsters challenged with virulent M. pneumoniae as described by Barile et al. (2a) .
This paper reports the results of comparative studies to evaluate attachment of radiolabeled M. pneumoniae to hamster tracheal organ cultures, tracheal outgrowth monolayers, human erythrocytes, and WiDr human carcinoma cell cultures. Virulent M. pneumoniae readily attached to each of the cell substrates that we examined, but WiDr cell culture monolayers (11 to 17 ultracentrifuged, and the supernatant was dialyzed and lyophilized. For inhibition studies, the lyophilized extract was suspended in HBSS (1 to 4 mg of protein per ml). Lots 25 and LL7 were prepared from strain M129, and LL2 and LL11 were from strain PI-1428.
Hamster tracheal ring organ cultures and outgrowth monolayers. Hamster tracheal explants were prepared as previously described (9, 11) and cultured in Eagle minimal essential medium with Earle salts supplemented with 2 mM glutamine, 1,000 U of penicillin-G per ml, and 10% heat-inactivated fetal calf serum (K-C Biologicals, Kansas City, Mo.) (EMEM-FCS) in 95% air-5% CO2.
Tracheal outgrowth monolayers (17) were obtained by placing freshly prepared hamster tracheal rings on 5-mm cover slips (Beilco Glass, Inc., Vineland, N.J.) in 35-mm plastic petri dishes containing 0.5 ml of EMEM-FCS and were maintained in a humidified atmosphere of 95% air-5% CO2 at 36°C. Cellular outgrowth onto the cover slip occurred in 3 to 5 days, and confluent monolayers were produced in about 2 weeks. The medium was replaced twice per week.
M. pneumoniae cytadsorption to cell culture monolayers. Cell cultures maintained in EMEM-FCS and 95% air-5% CO2 were infected after 24 h of incubation with approximately 106 CFU of M. pneumoniae (strain PI-1428, FH, or Mac). The cell cultures were examined 2 to 6 days later with a DNA staining procedure (3 Mass.) and 3 drops of glacial acetic acid were added, and the radioactivity was determined by liquid scintillation spectrometry.
(ii) Tracheal outgrowth monolayers. For M. pneumoniae attachment studies, the tracheal organ cultures that had been incubated on cover slips were removed, and the resulting monolayers on the cover slips were transferred to wells of flat-bottom microtiter plates containing 100 ,ul of HBSS. Cover slips incubated in medium alone, without tracheal explants, were included as negative controls to assess mycoplasma attachment to glass. Tritiated M. pneumoniae preparations (25 pl) were added, and the plates were incubated at 36°C for 2 h. The unattached mycoplasmas were removed, and the cover slips bearing the tracheal outgrowth monolayers and attached mycoplasmas were washed, blotted, and counted as described above for the tracheal organ cultures.
(iii) Human 0-positive erythrocytes. Attachment studies were performed as described by Banai et al. with shaking for 30 min, 0.5 ml of buffer A at 4°C was added, and the tubes were centrifuged at 400 x g for 1 min. The pellet of each incubation was washed twice, transferred to another tube, digested with sodium dodecyl sulfate and H202, and counted in duplicate as described previously (1) .
(iv) WiDr cell cultures. M. pneumoniae attachment was measured by adapting the erythrocyte procedure (1) to cell cultures. WiDr cell monolayers on 5-mm glass cover slips were washed with HBSS and transferred to siliconized (Sigmacote, Sigma Chemical Co., St. Louis, Mo.) borosilicate culture tubes (12 by 75 mm) containing 50 ,ul of HBSS; then 50 ,ul of radiolabeled M. pneumoniae (5 to 20 ,ug of protein, 710 to 2,359 cpm/p.g) was added to each tube. Cover slips that were incubated in medium without cells were included as negative controls to measure mycoplasma attachment to glass. The tubes were incubated on an orbital shaker at 36°C for 1 h and then cooled to room temperature. The unattached organisms were removed by aspiration, and the monolayers were washed twice with 0.5 ml of HBSS. The monolayers with adherent mycoplasmas were transferred to minivials, and 50 ,u of Protosol was added. The samples were digested for 2 h at 36°C, neutralized with 2 drops of glacial acetic acid, and counted with 3 The effect of the age of the organ culture explant on attachment was also examined. Attachment of M. pneumoniae to the tracheal organ cultures increased with the age of the explant culture (Table 1) . At day 2, attachment was 70% greater than that observed for freshly prepared explants at day 0. In other experiments, the increased mycoplasma attachment to tracheal explants after 1 to 2 days of culture was greater than twofold. These findings suggest that changes occur during culture of the hamster tracheal explants which result in altered activity of the explants. These changes affect the reproducibility of results in the attachment assay.
Hamster tracheal outgrowth monolayers. When hamster tracheal explants are placed on cover slips, cells from the mucosal surface of the trachea migrate onto the cover slip, forming a monolayer (17) . Up to 20%6 of these are epithelial cells with beating cilia. These epithelial outgrowth monolayers were examined for M. pneumoniae attachment. Attachment of M. pneumoniae strains PI-1428 and M129 to the outgrowth monolayers was detected within 2 h, and attachment to cover slips without cellular outgrowth (nonspecific background controls) was less than 7% of the specific attachment to cells (Table 2) growth monolayers in the attachment inhibition assays.
Human erythrocytes. The attachment of M. pneumoniae to human erythrocytes was examined by using the procedures of Banai et al. (1) . Washed human 0-positive erythrocytes were incubated with radiolabeled M. pneumoniae strain M129, and erythrocytes bearing attached mycoplasmas were sedimented and washed by low-speed centrifugation. Net attachment of M. pneumoniae to the erythrocytes was readily measured and was proportional to the amount of mycoplasma added (Fig. 2) . However, quantitative measurements of attachment inhibition, using the erythrocyte substrate and centrifugation procedures, were severely limited because of high background counts in negative controls; mycoplasma aggregates in the control tubes were also sedimented during centrifugation, resulting in high nonspecific background values. The sedimentation of M. pneumoniae aggregates in the absence of erythrocytes was about 40% of the specific attachment to erythrocytes (Table  3) . These high values for controls limit the sensitivity of attachment inhibition assays and restrict the usefulness of cells in suspension for detecting attachment inhibition.
WiDr ceil monolayer. Because cells in suspension were not suitable for attachment inhibition studies, procedures were developed in which cell culture monolayers were used as the substrate for attachment. A number of cell cultures were examined for cytadsorption of M. pneumoniae by using a DNA staining procedure (3). Comparative studies (not reported here) indicated that the WiDr cell line was superior for M. pneumoniae attachment. Attachment of radiolabeled M. pneumoniae to the WiDr cell culture monolayers was then examined by using a modification of procedures described by Banai et al. detecting attachment inhibition activity in the protein extract.
DISCUSSION
In this study, we examined and compared the usefulness of hamster tracheal organ cultures, tracheal outgrowth monolayers, human erythrocytes, and human WiDr cell cultures as cell substrate models for quantitating mycoplasma attachment and attachment inhibition. The findings indicated that virulent strains of M. pneumoniae readily attached to each of the mammalian cell substrates that we examined, but the cell substrates that were used were not equally suitable for quantitating attachment inhibition. Tracheal organ cultures contain different cell types, and nonspecific binding to nonciliated surfaces of the tracheal culture poses serious technical problems (13, 16) . Our studies showed that the age of the organ culture explants affected the We have also shown that WiDr cell culture monolayers can be used effectively for detecting attachment inhibition by an extract of M. pneumoniae which possesses hemagglutinating activity (6) ( Table 4) . Inhibition of attachment is probably due to competition between the mycoplasmal binding component in the extract and whole mycoplasmas for receptor sites on the mammalian cell. However, other mechanisms may be involved; for example, the receptor sites may be destroyed or altered by proteolytic or other activities in the extract and cannot be excluded. Gabridge et al. (18, 19) reported that neuraminidase treatment of MRC-5 human lung fibroblasts reduced the attachment of M. pneumoniae by more than 90%o. M. pneumoniae attachment to hamster tracheal organ cultures was also reduced by neuraminidase treatment (9, 16, 22) , which implies a role for a sialic acidcontaining component in M. pneumoniae attachment. Consistent with this concept, we observed that attachment of M. pneumoniae to the WiDr cell monolayers was inhibited by gangliosides and certain sialic acid-containing glycoproteins (Chandler and Barile, manuscript in preparation).
In sum, the WiDr monolayer attachment assay provides an excellent cell model for examining attachment inhibition activity. Inhibition of attachment to WiDr cell monolayers is presently being used to assay and characterize the binding component in the extract. If antibodies that inhibit mycoplasma attachment can prevent subsequent disease, the mycoplasmal binding component should provide an important immunogen for immunization against M. pneumoniae. Preliminary data suggest that the extract can protect hamsters from disease after challenge with virulent M. pneumoniae (2a) .
